VOYA Investment Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

VOYA Investment Management’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,646	Closed	-$31K	–	2681
2018 Q1	$31K	Buy	3,646 +1,526	+72%	+$12.7K	﹤0.01%	2566
2017 Q4	$20K	Hold	2,120	–	–	﹤0.01%	2585
2017 Q3	$25K	Hold	2,120	–	–	﹤0.01%	2622
2017 Q2	$89K	Buy	+2,120	New	+$102K	﹤0.01%	2608
2016 Q2	–	Sell	-1,282	Closed	-$79K	–	2604
2016 Q1	$79K	Hold	1,282	–	–	﹤0.01%	2437
2015 Q4	$54K	Hold	1,282	–	–	﹤0.01%	2533
2015 Q3	$70K	Hold	1,282	–	–	﹤0.01%	2533
2015 Q2	$141K	Buy	+1,282	New	+$119K	﹤0.01%	2579

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VOYA Investment Management's GNCA Position: Q2 2018 in Review

VOYA Investment Management sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2018, closing a stake of 3,646 shares — an estimated $31K sold.

VOYA Investment Management first reported a position in GNCA in Q2 2015 and held it in 8 quarters. The position peaked at $141K in Q2 2015. 54 funds tracked by Wall St. Rank hold GNCA as of Q2 2018.

VOYA Investment Management reported no remaining Genocea Biosciences, Inc. position as of Q2 2018 after selling out during the quarter.
VOYA Investment Management sold 3,646 Genocea Biosciences, Inc. shares in Q2 2018, an estimated $31K.
VOYA Investment Management first reported a position in Genocea Biosciences, Inc. in Q2 2015 and held it in 8 quarters.
VOYA Investment Management's Genocea Biosciences, Inc. position peaked at $141K in Q2 2015.
54 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2018.

Based on VOYA Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.